Tag: Drug Enforcement Adminsitration

DEA Approves Study of Ecstasy for Anxiety Associated with Life-Threatening Illness

The Drug Enforcement Adminsitration (DEA) has approved a study of MDMA (pure ecstasy) for the treatment of anxiety associated with terminal illnesses. “On March 13, 2015, the U.S. Drug Enforcement Administration approved the Schedule I license for Phil Wolfson, M.D., the Principal Investigator for our upcoming study of MDMA-assisted psychotherapy for anxiety associated with life-threatening …

Continue reading